Summary & Overview
CPT 54135: Radical Penectomy with Bilateral Inguinal Lymphadenectomy
CPT code 54135 denotes radical penectomy with bilateral inguinal lymphadenectomy, a major oncologic operation used for advanced or refractory penile cancer. Nationally, this code represents definitive surgical management for cases where tumor size, depth, or failure of conservative treatments necessitate removal of the entire organ and associated regional lymph nodes. The procedure has implications for surgical oncology capacity, post‑operative inpatient resources, and long‑term survivorship and rehabilitation services.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise clinical context for the code, an overview of settings where the service is typically performed, and what to expect in claims and billing workflows for major ablative urologic oncology procedures. The publication summarizes benchmark considerations, common modifiers and reporting practices, and highlights policy and coverage elements relevant to high‑acuity inpatient surgical care. This information is intended to aid coding professionals, revenue cycle staff, and clinical leaders who manage complex oncologic surgeries and related claims.
Billing Code Overview
CPT code 54135 describes a radical penectomy with bilateral inguinal lymphadenectomy — a surgical procedure in which the entire penis is removed along with all groin (inguinal) lymph nodes. The procedure is performed for extensive or treatment-refractory penile cancer when organ‑preserving therapies are not appropriate.
Service Type: Major ablative oncologic surgery
Typical Site of Service: Inpatient hospital surgical setting, often involving a multidisciplinary surgical team and postoperative inpatient care.
Clinical & Coding Specifications
Clinical Context
A typical patient is a male in his 50s–70s with a biopsy-proven, locally advanced squamous cell carcinoma of the penis that is refractory to local therapies or demonstrates extensive primary tumor involvement and regional nodal disease. The clinical workflow begins with multidisciplinary evaluation (urology, medical oncology, radiation oncology, and pathology), staging with physical exam and imaging (CT/MRI and possible PET), and discussion of risks, benefits, and alternatives. Preoperative optimization includes informed consent, review of comorbidities (cardiopulmonary status, anticoagulation management, diabetes control), and counseling regarding urinary diversion and reconstructive options. On the day of surgery the patient undergoes radical penectomy with bilateral inguinal lymphadenectomy under general anesthesia; intraoperative considerations include meticulous hemostasis, preservation or reconstruction of urethral length for perineal urethrostomy, and placement of drains. Postoperative care involves pain control, wound and flap monitoring, drain management, DVT prophylaxis, pathology review of margins and nodal status, and coordination of adjuvant therapy if indicated. Long-term follow-up addresses oncologic surveillance, psychosocial support, prosthetic or reconstruction referrals, and sexual and urinary function counseling.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal or typical procedural service | Use when the procedure is performed under routine circumstances without unusual circumstances. |